BioInnovator Spotlight Podcast
1) Ségolène Martin, CEO and co-founder of Kantify
Artificial Intelligence (AI) technologies are revolutionizing almost every field. Drug discovery - the process of identifying druggable targets and potential therapeutic compounds - is a long, costly,...Show More
2) Jack Reid and Adam Glen, co-founders of Unicorn Biotechnologies
Mammalian cell culture is difficult to scale up. Many cell types do not grow well in suspension and preferably attach to surfaces like the bottom of their flasks. Currently, researchers examine this g...Show More
3) Kianti Figler, CEO and co-founder of Upstream Foods
Alternative meat products are a simple answer to the challenge of sustainably feeding a growing population worldwide. These foods, often made from plants and fungi, mimic existing familiar meat produc...Show More
4) Priyanka Dutta-Passecker, CEO of Healiva
Chronic wounds affect over 156 million people worldwide. These are skin wounds that fail to heal or heal slowly but recur. Common causes may include burns, trauma, infection, and cancer, and they can ...Show More
5) Julia Eschenbrenner, CEO of PoroUS
Age-related illnesses have a dramatic impact on quality of life as global populations continue to grow older. Among these conditions, bone health has a significant impact as deterioration can lead to ...Show More
6) Torbjørn Furuseth, CEO and co-Founder of DoMore Diagnostics
Cancer therapies such as chemo and radiotherapy can be extremely aggressive but, for many patients and their clinicians, preserving quality of life is a major factor in choosing their treatment. Today...Show More
7) Arsenii Zabirnyk, Leader of the Calinhib project
Thousands of patients require heart valve surgery each year as a result of calcification. Currently, only surgical heart valve replacements are available as treatments - the two major options each hav...Show More
8) Dr Uirá Souto Melo, leader of the Lucid Genomics project
While many diseases are now known to have genetic components, many of the specific mutations involved are unknown in 60-70% of patients. Our DNA contains vast non-coding regions that Uirá Melo likens ...Show More
9) Antonis Katsoulas, project leader of Innunity
Multiple sclerosis (MS) has been characterised for many years, not just as a disease, but as a syndrome. It affects different phases of the immune system from the brain to the spinal cord and the peri...Show More
10) Elena Rueda, CEO and co-founder of Dama Health
Nearly 900 million women worldwide use reversible contraception, but finding the right method can be difficult. One-third of women stop using contraception due to varying side effects caused by differ...Show More